TransCode Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$6.8 | −$18 | −$4.9 | −$4.3 | −$12 | −$2.3 | −$5.2 | −$3.3 | |
| −$7.17 | −$21.28 | −$5.82 | −$5.13 | −$70.16 | −$146.06 | −$680.23 | −$21.35 | |
| 1 | 0.9 | 0.8 | 0.8 | — | — | — | — |
Trend